EVALUASI PENGGUNAAN OBAT ANTIDIABETIKA PADA PROGRAM RUJUK BALIK DI APOTEK X KABUPATEN JAYAPURA

Nawang Wulan Nago Pitasari; Risna Risna

doi:10.31596/cjp.v8i2.238

EVALUASI PENGGUNAAN OBAT ANTIDIABETIKA PADA PROGRAM RUJUK BALIK DI APOTEK X KABUPATEN JAYAPURA

DOI: https://doi.org/10.31596/cjp.v8i2.238

Nawang Wulan Nago Pitasari^(1*), Risna Risna⁽²⁾

(1) Prodi Farmasi, Sekolah Tinggi Ilmu Kesehatan Jayapura
(2) Prodi Farmasi, Sekolah Tinggi Ilmu Kesehatan Jayapura
(*) Corresponding Author

Abstract

The availability of Refer-Back Program (DRR) drugs is one of the factors in the success of DRR services in health facilities. The purpose of this study was to determine the quantity of use of antidiabetic drugs with the ATC / DDD and DU methods of 90% and the percentage of conformity of antidiabetic drugs with the National Formulary (Fornas). The method used is a type of cross-sectional observational research with a descriptive approach. Retrospective data collection for the period January-December 2022 at Apotek X BPJS Kesehatan Network in the Jayapura regency area. The results of this study showed that the most use of antidiabetic drugs was metformin (5,715.8 DDD / 1,000 / year). Antidiabetics included in the 90% DU segment are metformin, novorapid®, gliquidone and glimepiride and the level of prescribing compliance with Fornas reaches 100%.

Keywords

Antidiabetic; ATC/DDD; DU 90%; BRP

Full Text:

PDF

Article Metrics

Abstract viewed : 308 times |

PDF files downloaded : 250 times

References

Azoulay, Lindner, & Aniello. (2010). Determinants of cholesterol and triglycerides recording in patients treated with lipid lowering therapy in UK primary care. Pharmacoepidemiology and Drug Safety, 16(January), 228–228. https://doi.org/10.1002/pds

Dinas Kesehatan Kabupaten Jayapura. (2021). Profil Kesehatan Kabupaten Jayapura Tahun 2020.

Katzung. (2010). Basic & Clinical Pharmacology. In Basic & Clinical Pharmacology (Vol. 41).

Kemenkes RI. (2017). Petunjuk Teknis Evaluasi Penggunaan Obat di Fasilitas Kesehatan. Jakarta: Kementerian Kesehatan Republik Indonesia.

Kemenkes RI. (2022). Indikator Nasional Mutu Pelayanan Kesehatan Tempat Praktik Mandiri Dokter dan Dokter Gigi, Klinik, Pusat Kesehatan Masyarakat, Rumah Sakit, Laboratorium Kesehatan, dan Unit Transfusi Darah. Advanced Drug Delivery Reviews, 89–91.

King, P., Peacock, I., & Donnelly, R. (1999). UKPDS: clinical and therpeutic implications for DM2. British Journal of Clinical Pharmacology, 1–6. papers2://publication/uuid/9B695083-6086-405A-A037-C62EAC7C1E12

Maryani, H., Kristiana, L., Andarwati, P., Paramita, A., & Aimanah, U. (2019). Program Rujuk Balik Di Fasilitas Kesehatan Tingkat Pertama ( Studi Kasus Di Puskesmas Dan Apotek Di Surabaya ) Program in the First Level of Health Facilities. 99–105.

Medisa, D., Sulanto, D. S., & Rustamaji. (2015). 97910-ID-kesesuaian-resep-dengan-standar-pelayana. Jurnal Ilmiah Farmasi, 11(1), 20–28.

Meisaroh, D., Nasyanka, A. L., & Arizka, H. E. (2020). Profil Kesehatan Penulisan Resep pada Pasien Bedah Mitra Sehat Lamongan. 01(02), 24–28.

Nabilah, T., Dewi, N. M. A. R., & Aini, S. R. (2023). Evaluasi kesesuaian peresepan obat terhadap formularium nasional di Rumah Sakit Umum Daerah Sumbawa tahun 2021. Sasambo Journal of Pharmacy, 4(1), 14–18. https://doi.org/10.29303/sjp.v4i1.204

Nasyanka, A. L. (2020). Profil Kesesuaian Penulisan Resep Pada Pasien Umum Rawat Inap Dengan Formularium Di Rumah Sakit Bedah Mitra Sehat Lamongan. Journal of Herbal, Clinical and Pharmaceutical Science (HERCLIPS), 1(02), 24. https://doi.org/10.30587/herclips.v1i02.1414

Perkumpulan Endokrinologi Indonesia (PERKENI). (2021). Pengelolaan dan Pencegahan Diabetes melitus Tipe 2 di Indonesia 2021. PB PERKENI: Jakarta. https://pbperkeni.or.id/wp-content/uploads/2021/11/22-10-21-Website-Pedoman-Pengelolaan-dan-Pencegahan-DMT2-Ebook.pdf

Perpres RI. (2017). Instruksi Presiden Republik Indonesia Nomor 8 Tahun 2017 Tentang Optimalisasi Pelaksanaan Program Jaminan Kesehatan Nasional. 1–23.

Rika, P. Z., & Sulung, N. (2022). Analisis Pelaksanaan Program Rujuk Balik Di Puskesmas Kota Bukittinggi Tahun 2021. Human Care Journal, 7(1), 104. https://doi.org/10.32883/hcj.v7i1.1453

Sa’diyah, H., & Nuraini, A. (2021). Profil Kesesuaian Peresepan Obat Pasien Bpjs Dengan Formularium Nasionaldi Puskesmas Bangkalan Periode Januari-Maret 2020. Indonesian Journal Pharmaceutical and Herbal Medicine, 1(1), 5–9. http://jurnal.akfaryannas.ac.id/index.php/IJPHM/article/view/2

Saenz, Esteban, Mataix, Segura, Figuls, & Moher. (2015). Clinical Diabetes Mellitus—A Problem-Oriented Approach. The Cochrane Library, 10(1), 527–527. https://doi.org/10.2337/diacare.10.4.527

Safitri, della ayu, Yuliastuti, F., & Santoso, S. B. (2022). Gambaran Ketersediaan Obat Dengan E-Purchasing Untuk Pasien Program Rujuk Balik Di Fasilitas Kesehatan Tingkat I Di Apotek Wonosari Periode Desember 2020. Gastronomía Ecuatoriana y Turismo Local., 2(1), 2798–3552.

Srivanichakorn, W., Sriwijitkamol, A., Kongchoo, A., Sriussadaporn, S., Plengvidhya, N., Lertwattanarak, R. A., Vannasaeng, S., & Thongtang, N. (2015). Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: A randomized controlled trial. Diabetes, Metabolic Syndrome and Obesity, 8, 137–145. https://doi.org/10.2147/DMSO.S78008

Tanner, A. E., Ranti, L., & Lolo, W. A. (2015). Evaluasi Pelaksanaan Pelayanan Resep Obat Generik Pada Pasien Bpjs Rawat Jalan Di Rsup. Prof. Dr. R.D. Kandou Manado Periode Januari-Juni 2014. Pharmacon, 4(4), 58–64.

Wulandari, Y., Padmasari, S., & Larasati, N. (2021). Evaluasi Rasionalitas Penggunaan Obat Antidiabetik pada Pasien Diabetes melitus Tipe 2 Rawat Jalan. 2–3.

Yulianti, S. R., Mukaddas, A., & Faustine, I. (2021). Profil Pengobatan Pasien Diabetes Mellitus Tipe 2 Di Instalasi Rawat Inap Rsud Undata Palu Tahun 2021. Jurnal of Natural Science, 3(March), 40–46.

DOI: https://doi.org/10.31596/cjp.v8i2.238